Progress-PME has already actively helped many companies to develop and implement new (bio) pharmaceutical processes. We are well acquainted with upscaling from lab scale to production facility, implementation of new production processes and optimisation of existing processes. We have also earned our stripes in the related qualification projects, for example qualification of installations, (QC) equipment, cleaning processes, computer systems and, of course, the actual production processes. We use a risk-based approach according to ICH Q8 and Q9.
Our services
To determine the critical processes, installations or functionality in your organisation, we conduct a risk analysis using various risk analysis methods based on ICH Q8 and Q9. We then use the results to assess critical processes, installations or functions in closer detail. The final results of the risk analyses help us set up the right development, implementation and qualification strategy. Before doing so, we map all the possibilities and impossibilities and risks, resulting in better planning and budgeting.
Our staff
Our staff are experts in this method and guide your projects through the various phases according to schedule and budget. They do this from the following roles:
During the project, Progress-PME uses the applicable guidelines and advisory documents, including ISPE, GMP, FDA and GAMP.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.